Arkolith/Insider Trading/VRDN/Form 4/A

Violin Jonathan

Chief Executive Officer, DirectorViridian Therapeutics, Inc.\DE (VRDN) · full profile →Form 4/A · filed Feb 7, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.8M
Net Open-Market Flow
-$1.8M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 2, 2023Sell(S)50K$36.80$1.8M481K
Feb 2, 2023Option exercise(M)50K$0.15$8K531K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 2, 2023Option exercise(M)50K—$0239K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0000899243-23-004233) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML

Keep exploring

Connected pages for Viridian Therapeutics, Inc.\DE

Build

Ask your agent about VRDN insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0000899243-23-004233"
Ask your agent
Use Arkolith to summarize insider buying and selling at Viridian Therapeutics, Inc.\DE
over the last 90 days and cite the filings.